- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07948252
Phrenic Nerve-Guided Interscalene Block: Diaphragm Paralysis and Analgesia
The Effect of Using the Phrenic Nerve as a Landmark During Ultrasound-Guided Interscalene Block on the Incidence of Diaphragmatic Paralysis and Analgesic Efficacy in Patients Scheduled for Shoulder Surgery: A Prospective, Randomized Study
The primary objective of this prospective clinical study is to evaluate the incidence of hemidiaphragmatic paralysis when the phrenic nerve is utilized as a primary sonographic landmark during interscalene brachial plexus blocks. While interscalene blocks provide excellent analgesia for shoulder surgeries, they are frequently associated with unintended phrenic nerve blockade, leading to diaphragmatic paresis or paralysis. This study hypothesizes that utilizing the phrenic nerve as a specific landmark to guide local anesthetic injection will [reduce] the frequency of diaphragmatic paralysis while maintaining adequate surgical anesthesia.
Studieoversikt
Status
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: BARAN NAS
- Telefonnummer: 00905547501481
- E-post: hessam_nas@hotmail.com
Studer Kontakt Backup
- Navn: Müge ÇAKIRCA
- Telefonnummer: 00905054433177
- E-post: mugecakirca@gmail.com
Studiesteder
-
-
Altindağ
-
Ankara, Altindağ, Tyrkia (Türkiye), 06000
- Ankara Etlik City Hospital
-
Ta kontakt med:
- BARAN NAS
- Telefonnummer: 00905547501481
- E-post: hessam_nas@hotmail.com
-
Ta kontakt med:
- MUGE ÇAKIRCA
- Telefonnummer: 00905054433177
- E-post: mugecakirca@gmail.com
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients aged between 18 and 75 years.
- American Society of Anesthesiologists (ASA) physical status I, II, or III.
- Scheduled for elective arthroscopic shoulder surgery.
- Patients who are informed about the study and provide written informed consent.
Exclusion Criteria:
- Known allergy to local anesthetics.
- Presence of infection at the application/injection site.
- Severe coagulopathy disorder or the use of anticoagulants.
- Diagnosis of contralateral phrenic nerve palsy or severe Chronic Obstructive
- Pulmonary Disease (COPD).
- History of chronic opioid use or neuropathic pain.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Active Comparator: Intrafascial Injection Group
In this group, interscalene anatomical structures and the phrenic nerve will be visualized under ultrasound guidance. A volume of 10 ml of local anesthetic solution will be injected directly into the brachial plexus sheath (intrafascial plane) |
Under ultrasound guidance, the interscalene brachial plexus and the phrenic nerve will be directly visualized on the anterior scalene muscle to be used as a landmark. A total of 10 ml of [Local anesthetic medication name, e.g., 0.5% Bupivacaine] solution will be injected strictly into the intrafascial plane, inside the nerve sheath |
|
Eksperimentell: Experimental: Extrafascial Injection Group
In this group, interscalene anatomical structures and the phrenic nerve will be visualized under ultrasound guidance. A volume of 10 ml of local anesthetic solution will be injected outside the brachial plexus nerve sheath (extrafascial plane) |
Under ultrasound guidance, the interscalene brachial plexus and the phrenic nerve will be directly visualized on the anterior scalene muscle to be used as a landmark. A total of 10 ml of [Local anesthetic medication name, e.g., 0.5% Bupivacaine] solution will be injected strictly into the extrafascial plane, outside the nerve sheath |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Transient Hemidiaphragmatic Paralysis
Tidsramme: At postoperative minute 0 and minute 30
|
The incidence of transient diaphragmatic paralysis (phrenic nerve paresis) will be evaluated by measuring diaphragmatic excursion using diaphragm ultrasonography |
At postoperative minute 0 and minute 30
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Pain Scores
Tidsramme: Postoperative 1st, 3rd, 6th, 12th, and 24th hours
|
Postoperative pain severity will be assessed using the Numeric Rating Scale (NRS). The scale ranges from 0 to 10, where 0 represents 'no pain' and 10 represents 'worst imaginable pain'. Higher scores indicate a worse outcome (more severe pain) |
Postoperative 1st, 3rd, 6th, 12th, and 24th hours
|
|
Postoperative Total Opioid Consumption
Tidsramme: Postoperative 1st, 3rd, 6th, 12th, and 24th hours
|
The amount of total opioid consumption will be recorded during the postoperative follow-up period |
Postoperative 1st, 3rd, 6th, 12th, and 24th hours
|
|
Incidence of Dyspnea
Tidsramme: Up to 24 hours postoperatively
|
The presence of shortness of breath (dyspnea) complaints from the patients will be evaluated and recorded |
Up to 24 hours postoperatively
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: BARAN NAS, Ankara Etlik City Hospital (Ankara Etlik Sehir Hastanesi)
- Hovedetterforsker: MÜGE ÇAKIRCA, Ankara Etlik City Hospital (Ankara Etlik Sehir Hastanesi)
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AEŞH-EK-2026-133
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .